Osteoarthritis Trial, Recruiting NCT05946044 Sponsor: Wake Forest University Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT05946044
Recruiting Not Applicable 🇦🇺 Australian site

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are female
  • People with a Body Mass Index (BMI) of 30 or higher (this means a higher body weight relative to height)
  • People whose knee shows no signs of arthritis on both X-ray and MRI scans
  • People who have no knee pain, or knee pain on fewer than 15 days per month, in the knee being studied

Who may not be able to join:

  • People who have symptomatic or severe heart artery disease
  • People who are unable to walk without a walking aid or device
  • People who are blind
  • People who have type 1 diabetes
  • People currently receiving treatment for cancer
  • People who have had a knee fracture, or an ACL, MCL, or meniscus injury (with or without surgery) in the past 12 months
  • People who have had an injection into the knee in the past 6 months
  • People who have arthritis in both knees, as shown by X-ray or MRI scans
  • People who have frequent pain in both knees on more than 15 days per month
  • People with a BMI below 30
  • People who are male
  • People who experience claustrophobia (fear of enclosed spaces, such as an MRI machine)
  • People for whom MRI scanning is not safe — for example, those weighing over 300 pounds, or whose knee does not fit the MRI equipment
  • People who are unwilling or unable to make changes to their eating and physical activity habits due to their environment
  • People who cannot speak and read English
  • People who are planning to be away from the area for more than 2 months at any point during the 48-month study period

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Stephen P Messier, Ph.D., Wake Forest University

Phone: 336-758-3969

Australian sites

University of Sydney, Sydney,
+61 434 023 970

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Wake Forest University
Registry
ClinicalTrials.gov
Start date
21 March 2024
Est. completion
31 July 2029

Where this trial is recruiting

🇦🇺 Australia 🇺🇸 United States

1 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

Structural knee Osteoarthritis (OA) MRI change Scores

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov